Schilke Tobin was granted 434 shares, increasing direct ownership by 0.48% to 91,735 units (SEC Form 4)
Stocks in this Quantisnow insightHealth Care
Quantisnow market dataNASDAQ
RVNC
Revance Therapeutics Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2014
Original source Picked up and delivered by Quantisnow in real time